CompaniesCalAsia Pharmaceuticals

CalAsia Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

1,276

By Phase

PHASE3: 2PHASE2: 3

By Status

COMPLETED: 3RECRUITING: 2
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
Today
NCT05813847
NCT05831449
Hover over trial bars to see details

Recent Trials

NCT05831449Lead Sponsor
CPL-01 in the Management of Postoperative Pain After Bunionectomy
PHASE3Recruiting
574 participants
Started: May 22, 2023 · Completed: Dec 31, 2024
NCT05813847Lead Sponsor
Herniorrhaphy for Postoperative Pain
PHASE3Recruiting
504 participants
Started: Apr 18, 2023 · Completed: Dec 31, 2024
NCT05411861Lead Sponsor
Post-Operative Pain and Opioid Reduction Trial After Bunionectomy
PHASE2Completed
73 participants
Started: Jun 14, 2022 · Completed: Nov 7, 2022
NCT05080959Lead Sponsor
A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy
PHASE2Completed
105 participants
Started: Jul 28, 2021 · Completed: Jun 10, 2022
NCT04182880Lead Sponsor
Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain
PHASE2Completed
20 participants
Started: Jan 6, 2020 · Completed: Feb 28, 2020